{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-25-044940","form_type":"8-K","ticker":"PDSB","cik":"0001472091","company_name":"PDS Biotechnology Corp","filed_at":"2025-12-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.475166+00:00","generated_at":"2026-05-16T13:47:13.580713+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"PDS Biotech receives broad Japanese patent for lead candidate PDS0101","bullets":["Japan Patent Office issued Patent No. 7783866 for PDS0101 covering broad composition of matter and methods of use.","Patent expands PDS Biotech's IP portfolio in Japan; previously granted patents in US, China, Australia, Hong Kong.","Company anticipates patent and market protections for PDS0101 into the 2040s, including US biologics exclusivity.","PDS0101 is in Phase 3 trial for HPV16-positive recurrent/metastatic head and neck cancer.","CEO Frank Bedu-Addo stated the patent strengthens global IP and supports growth."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-25-044940","json":"https://secwatch.observer/filing/0001140361-25-044940.json","markdown":"https://secwatch.observer/filing/0001140361-25-044940.md","text":"https://secwatch.observer/filing/0001140361-25-044940.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1472091/000114036125044940/0001140361-25-044940-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1472091/000114036125044940/ef20060919_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T13:47:13.580713+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}